We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Developmental Transcriptional Diversity In Inhibitory Neurons

News   Jan 31, 2017 | Original Story From Université de Genève

 
Developmental Transcriptional Diversity In Inhibitory Neurons

Dayer Lab, UNIGE.

 
 
 

RELATED ARTICLES

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

Targeted Therapy Could Help Children With Deadly Nerve Cancer

News

Mount Sinai researchers have discovered a targeted therapy for adolescent patients with neuroblastoma, a deadly pediatric nerve cancer, who would otherwise have no treatment options.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE